Interleukin-4 receptor - Amgen

Drug Profile

Interleukin-4 receptor - Amgen

Alternative Names: Altrakincept; IL-4 receptor - Amgen; Nuvance; sIL-4R

Latest Information Update: 21 May 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Amgen
  • Class
  • Mechanism of Action Interleukin 4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma; Graft-versus-host disease; Hypersensitivity

Most Recent Events

  • 21 May 2002 Discontinued - Phase-I for Allergy in Germany (unspecified route)
  • 21 May 2002 Discontinued - Phase-I for Asthma in Canada (Inhalation)
  • 21 May 2002 Discontinued - Phase-I for Asthma in Germany (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top